OptimizeRx (OPRX) Non-Current Assets (2010 - 2026)

OptimizeRx's Non-Current Assets history runs 17 years deep, the most recent figure standing at $111.1 million for Q1 2026.

• In Q1 2026, Non-Current Assets fell 4.27% year-over-year to $111.1 million; the TTM figure through Mar 2026 stood at $452.5 million (up 47.85% YoY), while the FY2025 annual figure was $112.2 million, down 4.26% from the prior year.
• Non-Current Assets came in at $111.1 million for Q1 2026 at OptimizeRx, down from $112.2 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $128.9 million in Q4 2023 to a low of $25.4 million in Q1 2022.
• A 5-year average of $84.2 million and a median of $112.2 million in 2025 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets surged 257.3% in 2023 and decreased 9.23% in 2025, its largest moves.
• OptimizeRx's Non-Current Assets stood at $36.1 million in 2022, then soared by 257.3% to $128.9 million in 2023, then decreased by 9.07% to $117.2 million in 2024, then fell by 4.26% to $112.2 million in 2025, then retreated by 0.98% to $111.1 million in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $111.1 million, $112.2 million, and $114.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison